Treatment with Vyvgart (efgartigimod alfa-fcab) over two years was found to safely and effectively ease symptoms of generalized myasthenia gravis (gMG) among participants in an open-label extension study, according to an analysis of new data. “This analysis suggests that long-term efgartigimod [Vyvgart] treatment is well tolerated and…

Treatment with the experimental therapy zilucoplan eased symptoms of generalized myasthenia gravis (gMG) across different subgroups of patients participating in the Phase 3 RAISE clinical trial. Trial data showed treatment effects were consistent, regardless of sex, age, disease duration, prior use of certain treatments, or thymoma status. Findings…

Radiotherapy given after surgery to remove the thymus, called a thymectomy, eases symptoms of myasthenia gravis (MG) associated with a thymus tumor, and it can cut in half the time to a considerable recovery, a study from China found. Such recovery, known as minimal manifestation status, was defined as…

People who develop myasthenia gravis (MG) with very late onset — when they’re age 65 or older — may have a poor prognosis, particularly if they haven’t been started on immunotherapy, a study in China has found. These findings shine a light on how important it is to understand…

Robot-assisted surgery to remove the thymus is generally safe for people with myasthenia gravis (MG), with most patients who undergo the procedure seeing a reduction in symptom severity afterward, a study reports. “This retrospective follow-up study showed that robotic thymectomy [thymus removal surgery] is safe and feasible in patients…

Immunosuppressive therapies, administered with or without acetylcholinesterase inhibitors, helped ease symptoms of ocular myasthenia gravis (MG), according to an analysis of medical records from several hospitals in Japan. Although treatment was associated with favorable outcomes, some symptoms persisted in more than half the treated patients. Still, immunotherapy, including corticosteroids,…

A rare case of myasthenia gravis (MG) that preceded the onset of autoimmune encephalitis (AE) — a type of autoimmune disease affecting the brain — was described in a recent case report. The 24-year-old man, who didn’t test positive for MG-associated antibodies, but did have two distinct types of…

For people with rare health conditions like myasthenia gravis (MG), navigating the U.S. health insurance system can be difficult, but there are many resources that can support patients. Challenges with accessing healthcare and advice about overcoming them were the main topics of the “Navigating Insurance Coverage” panel discussion…

Life with myasthenia gravis (MG) often means finding new ways to do things that used to be easy but now are more challenging. In a workshop at the MG Foundation of America (MGFA) National Patient Conference, a group of panelists discussed how MG has impacted them, and shared some…

For people with myasthenia gravis (MG) and other chronic diseases, it’s important to be proactive in learning how to best manage the condition and connect with others in the disease community. “The first thing I really need to let you know is that you’re the only person who can…